Bio Rad Laboratories Inc
Change company Symbol lookup
Select an option...
BIO Bio Rad Laboratories Inc
RPRX Royalty Pharma PLC
NUE Nucor Corp
MORN Morningstar Inc
TOP TOP Financial Group Ltd
VEEV Veeva Systems Inc
ETY Eaton Vance Tax-Managed Diversified Equity Income Fund
FDX FedEx Corp
TARO Taro Pharmaceutical Industries Ltd
TIO Tingo Group Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profile

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.

Postmarket

Last Trade
Delayed
$379.76
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$379.76
Day's Change
0.76 (0.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
385.36
Day's Low
378.08
Volume
(Above Average)
Volume:
270,421

10-day average volume:
245,582
270,421

Upcoming Events

BIO's fiscal year ends in December
There are no upcoming events for BIO

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 4, 2023Q1 2023 Earnings Release$3.34$3.21 to $4.08$4.94
February 16, 2023Q4 2022 Earnings Release$3.31$3.34 to $3.62$3.21
October 27, 2022Q3 2022 Earnings Release$2.60$2.59 to $3.01$3.71
July 28, 2022Q2 2022 Earnings Release$3.38$2.46 to $2.98$3.54

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.